POMALYST
NATCO Pharma launches generic blood cancer treatment medicine in USNATCO Pharma has launched generic Pomalidomide capsules in the US. This drug treats blood and bone marrow cancer. It is a generic version o...
GSK blood cancer drug nearly halves risk of death in late-stage trialIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...
Stocks in the news: Axis Bank, Tata Motors, Adani Green, HUL, Lupin, Tata Power and NykaaAdani Green, Eicher Motors, Apollo Hospitals, Page Industries, Zomato, Trent, Jindal Steel , Indian Hotels, ConCor, Samvardhana Motherson a...
Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...
Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.
Natco Pharma launches generic blood cancer drug in IndiaNatco has launched pomalidomide capsules in strengths of 1 mg, 2 mg and 4 mg in India.
Load More